Benzylether derivatives

Details Benzylether derivatives Benzylether derivatives

2007-01-16

2007-01-16

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S215000, C548S235000

Reexamination Certificate

active

11131576

ABSTRACT:
Objects of the present invention are the compounds of formula (I)their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

REFERENCES:
patent: 1270571 (2003-01-01), None
patent: WO 98/03505 (1998-01-01), None
patent: WO 01/77107 (2001-10-01), None
patent: WO 03/031442 (2003-04-01), None
patent: WO 03/059907 (2003-07-01), None
Tasaka et al (2003), STN International CAPLUS database, Columbus (Ohio), accession No. 2003: 570981.
Wilks et al., Progress in Growth Factor Research, 2, pp. 97-111 (1990).
Chan et a., Cur. Opin. in Immunol., 8, pp. 394-401 (1995).
Yarden et al., Ann. Rev. Biochem., 57, pp. 443-478 (1988).
Wright et al., Br. J. Cancer, 65, pp. 118-121 (1992).
Baselga et al., Oncology, 63 (Suppl. 1), pp. 6-16 (2002).
Ranson et al., Oncology, 63 (Suppl. 1), pp. 17-24 (2002).
Bastin et al., Organic Proc. Res. Dev., 4, pp. 427-435 (2000).

Affiliated with

Also associated with

Rating

Benzylether derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzylether derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylether derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3727236